RNTX

Rein Therapeutics, Inc. Common Stock

19 hedge funds and large institutions have $20.7M invested in Rein Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
19
Holders Change
+19
Holders Change %
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Bank of America
1
Bank of America
North Carolina
$7.45M 668,177 +668,177 New
Jennison Associates
2
Jennison Associates
New York
$2.79M 250,000 +250,000 New
CS
3
Candriam SCA
Luxembourg
$1.67M 150,000 +150,000 New
SFM
4
Sphera Funds Management
Israel
$1.39M 125,000 +125,000 New
Millennium Management
5
Millennium Management
New York
$1.36M 122,078 +122,078 New
NC
6
Nexthera Capital
New York
$1.27M 114,108 +114,108 New
ECM
7
Endurant Capital Management
California
$993K 89,100 +89,100 New
MIM
8
Monashee Investment Management
Massachusetts
$836K 75,000 +75,000 New
HCM
9
Highbridge Capital Management
New York
$562K 50,434 +50,434 New
Norges Bank
10
Norges Bank
Norway
$558K 50,000 +50,000 New
Goldman Sachs
11
Goldman Sachs
New York
$418K 37,500 +37,500 New
MCM
12
Masters Capital Management
Georgia
$335K 30,000 +30,000 New
LCM
13
Laurion Capital Management
New York
$335K 30,000 +30,000 New
Neuberger Berman Group
14
Neuberger Berman Group
New York
$279K 25,000 +25,000 New
Citadel Advisors
15
Citadel Advisors
Florida
$141K 12,681 +12,681 New
ZP
16
Zimmer Partners
New York
$112K 10,000 +10,000 New
Tudor Investment Corp
17
Tudor Investment Corp
Connecticut
$112K 10,000 +10,000 New
Vanguard Group
18
Vanguard Group
Pennsylvania
$111K 10,000 +10,000 New
PMFA
19
Plante Moran Financial Advisors
Michigan
$3K 300 +300 New